Go to top of page

What's new

Australian Pilots not at higher risk of melanoma than other Australians

22 May 2019

Recently, ARPANSA co-authored a new study which found that modern airline pilots registered in Australia, appear not to be at higher risk of developing invasive melanoma than the rest of the population.

ARPANSA expands ultraviolet radiation monitoring

16 May 2019

We’re pleased to be partnering with the Central Highlands Regional Council to establish Queensland’s fourth location for collection of real time ultraviolet (UV) data.

ARPANSA authorises limited production of molybdenum-99 in the ANM facility

8 April 2019

ARPANSA has granted the Australian Nuclear Science and Technology Organisation (ANSTO) an amended license to allow for the limited production of molybdenum-99 in order to sustain supply.

human fingers turning a 4G cube into a 5G cube - the cube has writing '4G' and the writing is being moved to say '5G'

5G: the new generation of the mobile phone network and health

20 March 2019

At ARPANSA, we set the safety standard sets limits for exposure to radio frequency (RF) electromagnetic energy (EME) that is emitted by mobile phones and other wireless technologies. These limits are set well below levels at which harm to people may occur. The operating frequencies of the 5G network are included within the limits set by the ARPANSA safety standard.

new linear accelerator also known as linac with dummy or phantom

We have installed a new linear accelerator at ARPANSA

6 March 2019

We’re excited to announce that we have installed a new linear accelerator (linac) at ARPANSA, to continue ensuring any Australians undergoing medical procedures receive the correct amount of radiation.

Dr Carl-Magnus Larsson standing with glasses and a suit near flowers

Dr Carl-Magnus Larsson reappointed as CEO for a third term

5 March 2019

The Governor-General has reappointed Dr Carl-Magnus Larsson as the CEO of ARPANSA for a term of three years.

Close up of woman's face resting on bed wearing blocking sunglasses and about to be treated with a device by someone out of view

Do you work with or use cosmetic treatments using laser, IPLs or LEDs?

25 February 2019

We’ve released national advice for light-based cosmetic treatments in Australia for both patients and practitioners.

Hon. Senator Bridget McKenzie, Dr. Carl-Magnus Larsson and IRRS officials

The Integrated Regulatory Review Service Report is here

13 February 2019

The final report for the Integrated Regulatory Review Service (IRRS) mission to Australia has been released.

ARPANSA reviews animal study on radiofrequency exposure and health

14 January 2019

ARPANSA scientists have reviewed the recent National Toxicology Program (NTP) animal studies which looked at whether exposure to radiofrequency (RF) radiation causes any health effects, including cancer, in rats and mice.

Regulatory update

13 December 2018

The ARPANS Regulations 1999 and ARPANS Licence Charges Regulations 2000 have been repealed and replaced.

New Australian study finds no link between mobile phone use and brain cancers

11 December 2018

A study led by ARPANSA, published with the British Medical Journal Open, found no link between the use of mobile phones in Australia and incidence of brain cancers.

ARPANSA receives action plan from ANSTO following safety review

5 December 2018

On 4 December 2018, following a direction from ARPANSA’s CEO Dr Larsson, the Australian Nuclear Science and Technology Organisation (ANSTO) provided ARPANSA with an action plan that responds to 85

Hilaire Mansoux speaking to a crowded room

Australia commits to strengthening nuclear and radiation safety

16 November 2018

The Integrated Regulatory Review Service (IRRS) team today concluded their 12 day mission to benchmark Australia’s framework for nuclear and radiation safety against international best practice.

IRRS Mission Group shot with all counterparts

Openness, transparency and a commitment to improvement- IRRS opening 2018

5 November 2018

Today, the Integrated Regulatory Review Service (IRRS) mission was officially opened at ARPANSA. Officials emphasised the mission, reviewing Australia’s nuclear protection and radiation safety regulatory framework, shows international openness and transparency and a commitment to improvement.

Experts visit ARPANSA to review Australia’s regulatory framework and safety standards

2 November 2018

An International Atomic Energy Agency (IAEA) Integrated Regulatory Review Service (IRRS) mission will visit ARPANSA during 5–16 November 2018.

ARPANSA receives report from independent review team on ANSTO approach to safety

22 October 2018

On 5 October 2018, following a direction from ARPANSA’s CEO Dr Carl-Magnus Larsson, the Australian Nuclear Science and Technology Organisation (ANSTO) provided ARPANSA with a report produced by an

Image of front cover of Annual Report 2017-18

ARPANSA’s Annual Report 2017–18 released

17 October 2018

Our 2017–18 Annual Report was tabled in parliament on Wednesday 17 October 2018.

Image of ARPANSA's Gillian Hirth shaking hands with ANVS's Marco Brugmans

ARPANSA signs cooperative agreement with Dutch ANVS

1 October 2018

On 19 September 2018, at the International Atomic Energy Agency (IAEA) General Conference in Vienna, ARPANSA’s Deputy Chief Executive Officer, Gillian Hirth, alongside the Deputy Chairman of the Board of the Dutch Authority for Nuclear Safety and Radiation Protection (ANVS), Marco Brugmans, signed a memorandum of understanding (MoU).